German firms lead way for vaccine development in Europe

Biotech companies around the world are in a race against time to produce a vaccine for the #coronavirus. Governments are hopeful one can be approved by the end of the year, and allow the world economy to get back to normal. There are now 17 clinical trials for a #COVID19 vaccine underway worldwide. Most experts … Read more German firms lead way for vaccine development in Europe

Bitleague | Disrupt Berlin 2019

Bitleague is a commission-free banking service for digital currencies. The TC Top Picks program showcases outstanding early-stage startups across these categories: AI/Machine Learning, Biotech/Healthtech, Blockchain, Fintech, Mobility, Privacy/Security, Retail/E-commerce, Robotics/IoT/Hardware, SaaS and Social Impact & Education. TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech … Read more Bitleague | Disrupt Berlin 2019

COVID-19 patients’ plasma helping with immunity research | 7.30

Medical researchers and biotech companies are gearing up for a trial that could help COVID-19 patients fight off the virus using someone else’s antibodies. Alongside the race to develop a vaccine to prevent people contracting the virus in the first place, scientists are also working on ways to boost patients’ immune systems to speed recovery. … Read more COVID-19 patients’ plasma helping with immunity research | 7.30

Bin-e | Disrupt Berlin 2019

Bin-e is a smart waste bin that can recognize and sort the waste automatically with AI The TC Top Picks program showcases outstanding early-stage startups across these categories: AI/Machine Learning, Biotech/Healthtech, Blockchain, Fintech, Mobility, Privacy/Security, Retail/E-commerce, Robotics/IoT/Hardware, SaaS and Social Impact & Education. TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, … Read more Bin-e | Disrupt Berlin 2019

The First Covid Vaccines May Not Prevent Covid Infection

Desperation for a way to keep economies from collapsing under the weight of Covid-19 could mean settling for a vaccine that prevents people from getting really sick or dying but doesn’t stop them from catching the coronavirus. Although a knock-out blow against the virus is the ultimate goal, early vaccines may come with limitations on … Read more The First Covid Vaccines May Not Prevent Covid Infection

Usercentrics | Disrupt Berlin 2019

Usercentrics is a privacy consent management platform that helps companies collect and document consent of users in a GDPR-compliant way. The TC Top Picks program showcases outstanding early-stage startups across these categories: AI/Machine Learning, Biotech/Healthtech, Blockchain, Fintech, Mobility, Privacy/Security, Retail/E-commerce, Robotics/IoT/Hardware, SaaS and Social Impact & Education. TechCrunch is a leading technology media property, dedicated … Read more Usercentrics | Disrupt Berlin 2019

Brazil Announces Progress on Experimental Covid-19 Vaccine Developed With China

Sao Paulo’s Governor announced that Brazil’s Instituto Butantan and China’s Sinovac Biotech have signed an agreement to produce a coronavirus vaccine that will be available in the first half of 2021. Some 9,000 Brazilians will take part in the testing that’s planned to start at the beginning of July, representing the 3rd and last stage … Read more Brazil Announces Progress on Experimental Covid-19 Vaccine Developed With China

RadicalBit | Disrupt Berlin 2019

Radicalbit is a deeptech CRM and logistics platform. The TC Top Picks program showcases outstanding early-stage startups across these categories: AI/Machine Learning, Biotech/Healthtech, Blockchain, Fintech, Mobility, Privacy/Security, Retail/E-commerce, Robotics/IoT/Hardware, SaaS and Social Impact & Education. TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news. … Read more RadicalBit | Disrupt Berlin 2019

Exclusive: ‘99% chance’ COVID-19 vaccine will work, say Chinese scientists

Chinese scientists working on a COVID-19 vaccine have told Sky News they are “99%” sure it will be effective. Sinovac, a Beijing-based biotech company, currently has its coronavirus vaccine in stage 2 trials, with more than 1,000 volunteers participating. Our China Correspondent Tom Cheshire has visited the labs in Beijing and has this report. SUBSCRIBE … Read more Exclusive: ‘99% chance’ COVID-19 vaccine will work, say Chinese scientists

Bill Gates-backed biotech company starts phase 1 vaccine trial

A U.S.-based biotech company says it has started a phase one coronavirus vaccine trial with financial support from a group backed by Bill Gates. The trial, taking place in Australia, involves about 130 people aged between 18 and 59. If it’s successful, the Maryland-based company will follow up with trials in more countries. Meanwhile, Dow … Read more Bill Gates-backed biotech company starts phase 1 vaccine trial

Human trials begin in Melbourne today for a potential COVID-19 vaccine: Press conference | ABC News

Australia’s first human trials of a potential COVID-19 vaccine started in Melbourne today, with about 130 people involved in the program. Clinical research organisation the Nucleus Network will be in charge of the early stages of testing the vaccine NVX-CoV2373, before the trial expands to Brisbane within a week. The participants are healthy people between … Read more Human trials begin in Melbourne today for a potential COVID-19 vaccine: Press conference | ABC News

Moderna Vaccine Doubts Halt Rally

May.20 — Moderna shares are falling from an all-time high after investors digested a report questioning early data from a small trial of its potential coronavirus vaccine. The biotech company closed down 10% after Monday’s 20% gain. The gradual slide began when a report highlighted the early nature of the vaccine data. Bloomberg’s Annmarie Hordern … Read more Moderna Vaccine Doubts Halt Rally

MIT Professor’s Moderna Stake on Brink of Topping $1 Billion

Another early investor of Moderna Inc. is on the cusp of owning a stake worth at least $1 billion after the biotech firm reported encouraging early trial results for an experimental Covid-19 vaccine. The value of board member Bob Langer’s 3.2% holding, including stock options, rose to $934.3 million Monday, as the shares surged 20% … Read more MIT Professor’s Moderna Stake on Brink of Topping $1 Billion

US Covid-19 vaccine trial shows promising early results

Moderna Inc’s experimental COVID-19 vaccine, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, according to very early data released by the biotech company on Monday. Subscribe to France 24 now: http://f24.my/youtubeEN FRANCE 24 live news stream: all the latest news 24/7 http://f24.my/YTliveEN Visit our website: … Read more US Covid-19 vaccine trial shows promising early results

Moderna Announces ‘Encouraging’ Coronavirus Vaccine Trial Results

Moderna, a Massachusetts-based biotech company, says its experimental vaccine against the coronavirus showed ‘encouraging’ results in the early stages of testing. The vaccine triggered immune responses in 8 healthy, middle-aged volunteers by generating antibodies similar to those seen in people who have recovered from Covid-19. The next phase is determining the size of the dose … Read more Moderna Announces ‘Encouraging’ Coronavirus Vaccine Trial Results